haloperidol has been researched along with Brain Damage, Chronic in 19 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Brain Damage, Chronic: A condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders (see BRAIN DISEASES, METABOLIC); and other conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In fact, Reyes developed neuroleptic malignant syndrome (NMS) as a direct result of the antipsychotic medications she was administered." | 1.29 | Neuroleptic malignant syndrome: liability in nursing practice. ( Blair, DT; Dauner, A, 1993) |
| "A case of neuroleptic malignant syndrome (NMS) is described in a congenitally brain-damaged deaf patient." | 1.28 | Neuroleptic malignant syndrome and preexisting brain damage. ( Lazarus, A, 1992) |
| "Agitated patients with organic brain disorders represent relatively common diagnostic and management problems." | 1.26 | Treatment of the agitated patient with an organic brain disorder. ( Fauman, MA, 1978) |
| "Treatment with haloperidol in all patients and with dipropylacetic acid in three patients did not appear to modify the CSF, HVA, and 5HIAA concentrations, the plasma DBH activity, or the DA uptake." | 1.26 | Biochemical aspects of Huntington's chorea. ( Algeri, S; Branciforti, A; Calderini, G; Caraceni, T; Consolazione, A; Dall'olio, A; Girotti, F; Morselli, PL; Riva, E; Spreafico, R, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (73.68) | 18.7374 |
| 1990's | 5 (26.32) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| LEHMANN, HE | 1 |
| BAN, TA | 1 |
| KATO, G | 1 |
| GOZSY, B | 1 |
| KATO, L | 1 |
| Fialkov, MJ | 1 |
| Sonis, WA | 1 |
| Rapport, MD | 1 |
| Kazdin, AE | 1 |
| Frieboes, RM | 1 |
| Müller, U | 1 |
| von Cramon, DY | 1 |
| Blair, DT | 1 |
| Dauner, A | 1 |
| John, S | 1 |
| Ovsiew, F | 1 |
| Stanislav, SW | 1 |
| Fauman, MA | 1 |
| Caraceni, T | 1 |
| Calderini, G | 1 |
| Consolazione, A | 1 |
| Riva, E | 1 |
| Algeri, S | 1 |
| Girotti, F | 1 |
| Spreafico, R | 1 |
| Branciforti, A | 1 |
| Dall'olio, A | 1 |
| Morselli, PL | 1 |
| Schilkrut, R | 2 |
| Rüther, E | 2 |
| Ackenheil, M | 2 |
| Eben, E | 2 |
| Hippius, H | 2 |
| Werry, JS | 1 |
| Aman, MG | 1 |
| Lazarus, A | 1 |
| Turunen, S | 1 |
| Achté, KA | 1 |
| Rosin, AJ | 1 |
| Sand, P | 1 |
| Barr, RF | 1 |
| Lovibond, SH | 1 |
| Katsaros, E | 1 |
| Logue, PE | 1 |
| Platzek, D | 1 |
| Hutzell, R | 1 |
| Robinson, B | 1 |
| Shapiro, AK | 1 |
| Shapiro, E | 1 |
| Lapolla, A | 1 |
| Nash, LR | 1 |
1 review available for haloperidol and Brain Damage, Chronic
| Article | Year |
|---|---|
[Symptomatic acoustic hallucinations after traumatic brain damage. Review of the literature and case report].
Topics: Adult; Auditory Perceptual Disorders; Behavior Therapy; Brain Damage, Chronic; Brain Edema; Combined | 1994 |
1 trial available for haloperidol and Brain Damage, Chronic
| Article | Year |
|---|---|
A butyrophenone (haloperidol) for the treatment of institutionalized patients.
Topics: Adolescent; Adult; Aged; Antisocial Personality Disorder; Brain Damage, Chronic; Child; Clinical Tri | 1966 |
17 other studies available for haloperidol and Brain Damage, Chronic
| Article | Year |
|---|---|
POTENTIATION OF PHARMACOLOGICAL AND THERAPEUTIC ACTION OF PHENOTHIAZINES BY NYLIDRIN (ARLIDIN).
Topics: Bipolar Disorder; Brain; Brain Damage, Chronic; Chlorprothixene; Depressive Disorder, Major; Dextran | 1964 |
An interdisciplinary approach to the diagnosis and management of a complex case of postencephalitic behavioral disorder.
Topics: Adolescent; Aggression; Anticonvulsants; Brain Damage, Chronic; Child Behavior Disorders; Encephalit | 1983 |
Neuroleptic malignant syndrome: liability in nursing practice.
Topics: Adult; Antipsychotic Agents; Brain Damage, Chronic; Dose-Response Relationship, Drug; Female; Halope | 1993 |
Erotomania in a brain-damaged male.
Topics: Adult; Brain Damage, Chronic; Delusions; Hallucinations; Haloperidol; Humans; Intellectual Disabilit | 1996 |
Cognitive effects of antipsychotic agents in persons with traumatic brain injury.
Topics: Adult; Antipsychotic Agents; Brain Damage, Chronic; Brain Injuries; Cognition Disorders; Haloperidol | 1997 |
Treatment of the agitated patient with an organic brain disorder.
Topics: Adult; Aged; Antipsychotic Agents; Brain Damage, Chronic; Brain Diseases; Brain Injuries; Haloperido | 1978 |
Biochemical aspects of Huntington's chorea.
Topics: Adult; Age Factors; Blood Platelets; Brain Damage, Chronic; Dopamine; Dopamine beta-Hydroxylase; Fem | 1977 |
Clinical and biochemical parameters during neuroleptic treatment. II. Antipsychotic effect of haloperidol in patients with chronic organic brain damage.
Topics: Adult; Aged; Brain Damage, Chronic; Depression; Female; Hallucinations; Haloperidol; Homovanillic Ac | 1976 |
Clinical and biochemical parameters during neuroleptic treatment. III. Primitive reflexes during neuroleptic treatment.
Topics: Adult; Aged; Brain Damage, Chronic; Chin; Female; Forehead; Haloperidol; Hand; Humans; Lip; Male; Mi | 1976 |
The reliability and diagnostic validity of the physical and neurological examination for soft signs (PANESS).
Topics: Brain Damage, Chronic; Child; Child, Preschool; Evaluation Studies as Topic; Haloperidol; Humans; Hy | 1976 |
Neuroleptic malignant syndrome and preexisting brain damage.
Topics: Adult; Brain Damage, Chronic; Drug Therapy, Combination; Haloperidol; Humans; Male; Neuroleptic Mali | 1992 |
The bucco-linguo-masticatory syndrome as a side-effect of neuroleptics therapy.
Topics: Adult; Aged; Brain Damage, Chronic; Cheek; Chlorpromazine; Chlorprothixene; Clopenthixol; Female; Ha | 1967 |
Clinical features, etiology and treatment of facial dyskinesias in the elderly.
Topics: Age Factors; Aged; Brain; Brain Damage, Chronic; Brain Stem; Chorea; Dementia; Dopamine; Face; Femal | 1974 |
Neuropsychological test performance before and after symptom removal in a child with Guilles de la Tourette syndrome.
Topics: Behavior Therapy; Brain Damage, Chronic; Child; Diagnosis, Differential; Haloperidol; Humans; Intell | 1972 |
A case of Gilles de la Tourette's syndrome in a brain-damaged child.
Topics: Adolescent; Behavior Therapy; Brain Damage, Chronic; Family Therapy; Female; Haloperidol; Humans; To | 1972 |
Neurological, neuropsychological and behavioral aspects of Gilles de la Tourette's syndrome: a case.
Topics: Adolescent; Brain Damage, Chronic; Child; Cognition Disorders; Electroencephalography; Haloperidol; | 1973 |
Gilles de la Tourette's syndrome.
Topics: Adolescent; Brain Damage, Chronic; Child; Child, Preschool; Echolalia; Female; Haloperidol; Humans; | 1974 |